The Centers for Disease Control and Prevention holds patents on the use of Truvada for HIV prevention, according to advocates, who want Gilead Sciences to pay future and retroactive royalties to make ...
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes Zandraetta Tims-Cook, MD, MPH, AAHIVS In the US, we have made remarkable ...
According to CDC statistics, only 25% of the approximately 1.2 million Americans who could benefit from PrEP had prescriptions in 2020. As the Bay Area Reporter has previously reported, people of ...
Gilead Sciences Inc (NASDAQ:GILD) stock is trading lower during the premarket trading session on Wednesday. According to a Tuesday report in the Wall Street Journal, the Health and Human Services ...
The CDC has increased its funding to help states and communities become better prepared to track and respond to infectious diseases. This year, the agency will award roughly $110 million, a $13 ...
The Centers for Disease Control and Prevention estimates almost one-third of healthcare providers are unaware of pre-exposure prophylaxis’ benefits, according to Vaccine News. 1. When PrEP is taken as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results